Growth Metrics

Nephros (NEPH) Depreciation Expense (2019 - 2024)

Nephros (NEPH) has 11 years of Depreciation Expense data on record, last reported at $1000.0 in Q1 2024.

  • For Q1 2024, Depreciation Expense changed 0.0% year-over-year to $1000.0; the TTM value through Mar 2024 reached $3000.0, down 89.66%, while the annual FY2023 figure was $3000.0, 86.36% down from the prior year.
  • Depreciation Expense reached $1000.0 in Q1 2024 per NEPH's latest filing, roughly flat from $1000.0 in the prior quarter.
  • Across five years, Depreciation Expense topped out at $22000.0 in Q2 2022 and bottomed at -$5000.0 in Q4 2021.
  • Average Depreciation Expense over 4 years is $3900.0, with a median of $2000.0 recorded in 2022.
  • Peak YoY movement for Depreciation Expense: soared 175.0% in 2022, then crashed 95.45% in 2023.
  • A 4-year view of Depreciation Expense shows it stood at -$5000.0 in 2021, then surged by 160.0% to $3000.0 in 2022, then tumbled by 66.67% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Depreciation Expense were $1000.0 in Q1 2024, $1000.0 in Q3 2023, and $1000.0 in Q2 2023.